BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30380515)

  • 1. Daphnetin protects against cisplatin-induced nephrotoxicity by inhibiting inflammatory and oxidative response.
    Zhang L; Gu Y; Li H; Cao H; Liu B; Zhang H; Shao F
    Int Immunopharmacol; 2018 Dec; 65():402-407. PubMed ID: 30380515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperin inhibits nuclear factor kappa B and activates nuclear factor E2-related factor-2 signaling pathways in cisplatin-induced acute kidney injury in mice.
    Chao CS; Tsai CS; Chang YP; Chen JM; Chin HK; Yang SC
    Int Immunopharmacol; 2016 Nov; 40():517-523. PubMed ID: 27764742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthohumol attenuates cisplatin-induced nephrotoxicity through inhibiting NF-κB and activating Nrf2 signaling pathways.
    Li F; Yao Y; Huang H; Hao H; Ying M
    Int Immunopharmacol; 2018 Aug; 61():277-282. PubMed ID: 29906742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isovitexin protects against cisplatin-induced kidney injury in mice through inhibiting inflammatory and oxidative responses.
    Liu S; Zhang X; Wang J
    Int Immunopharmacol; 2020 Jun; 83():106437. PubMed ID: 32222637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling.
    Huang YC; Tsai MS; Hsieh PC; Shih JH; Wang TS; Wang YC; Lin TH; Wang SH
    Toxicol Appl Pharmacol; 2017 Aug; 329():128-139. PubMed ID: 28558962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danshensu attenuates cisplatin-induced nephrotoxicity through activation of Nrf2 pathway and inhibition of NF-κB.
    Yu C; Dong H; Wang Q; Bai J; Li YN; Zhao JJ; Li JZ
    Biomed Pharmacother; 2021 Oct; 142():111995. PubMed ID: 34435595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways.
    Ma X; Dang C; Kang H; Dai Z; Lin S; Guan H; Liu X; Wang X; Hui W
    Int Immunopharmacol; 2015 Sep; 28(1):399-408. PubMed ID: 26118633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of 6-hydroxy-1-methylindole-3-acetonitrile on cisplatin-induced oxidative nephrotoxicity via Nrf2 inactivation.
    Moon JH; Shin JS; Kim JB; Baek NI; Cho YW; Lee YS; Kay HY; Kim SD; Lee KT
    Food Chem Toxicol; 2013 Dec; 62():159-66. PubMed ID: 23989062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation of American ginseng berry extract mitigated cisplatin-evoked nephrotoxicity by suppressing ROS-mediated activation of MAPK and NF-κB signaling pathways.
    Ma ZN; Liu Z; Wang Z; Ren S; Tang S; Wang YP; Xiao SY; Chen C; Li W
    Food Chem Toxicol; 2017 Dec; 110():62-73. PubMed ID: 29024717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eriodictyol attenuates cisplatin-induced kidney injury by inhibiting oxidative stress and inflammation.
    Li CZ; Jin HH; Sun HX; Zhang ZZ; Zheng JX; Li SH; Han SH
    Eur J Pharmacol; 2016 Feb; 772():124-30. PubMed ID: 26723515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMF attenuates cisplatin-induced kidney injury via activating Nrf2 signaling pathway and inhibiting NF-kB signaling pathway.
    Zhao K; Wen LB
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8924-8931. PubMed ID: 30575936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-hydroxycoumarin modulates Nrf2/HO-1 and microRNA-34a/SIRT1 signaling and prevents cisplatin-induced oxidative stress, inflammation, and kidney injury in rats.
    Sami DH; Soliman AS; Khowailed AA; Hassanein EHM; Kamel EM; Mahmoud AM
    Life Sci; 2022 Dec; 310():121104. PubMed ID: 36270424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embelin attenuates cisplatin-induced nephrotoxicity: Involving inhibition of oxidative stress and inflammation in addition with activation of Nrf-2/Ho-1 pathway.
    Qin X; Meghana K; Sowjanya NL; Sushma KR; Krishna CG; Manasa J; Sita GJA; Gowthami M; Honeyshmitha D; Srikanth G; SreeHarsha N
    Biofactors; 2019 May; 45(3):471-478. PubMed ID: 30893507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piceatannol protects against cisplatin nephrotoxicity via activation of Nrf2/HO-1 pathway and hindering NF-κB inflammatory cascade.
    Wahdan SA; Azab SS; Elsherbiny DA; El-Demerdash E
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1331-1345. PubMed ID: 31197431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
    Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorate effect of pyrroloquinoline quinone against cyclophosphamide-induced nephrotoxicity by activating the Nrf2 pathway and inhibiting the NLRP3 pathway.
    Lin X; Yang F; Huang J; Jiang S; Tang Y; Li J
    Life Sci; 2020 Sep; 256():117901. PubMed ID: 32504759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
    Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
    Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhang W; Hou J; Yan X; Leng J; Li R; Zhang J; Xing J; Chen C; Wang Z; Li W
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daphnetin reduces endotoxin lethality in mice and decreases LPS-induced inflammation in Raw264.7 cells via suppressing JAK/STATs activation and ROS production.
    Shen L; Zhou T; Wang J; Sang X; Lan L; Luo L; Yin Z
    Inflamm Res; 2017 Jul; 66(7):579-589. PubMed ID: 28409189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daphnetin attenuates microglial activation and proinflammatory factor production via multiple signaling pathways.
    Yu W; Wang H; Ying H; Yu Y; Chen D; Ge W; Shi L
    Int Immunopharmacol; 2014 Jul; 21(1):1-9. PubMed ID: 24747094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.